Back to School: How biopharma can reboot drug development. Access exclusive analysis here

VX-680: Suspended Phase II enrollment

Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass.
Merck & Co. Inc. (MRK), Whitehouse Station, N.J.
Product: VX-680, MK-0457
Business: Cancer
Molecular target:

Read the full 225 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE